Skip to content
Thursday, March 20, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
19
USPTO allows patents for Remedy’s large hemispheric infarction drug
GLP-1 News
USPTO allows patents for Remedy’s large hemispheric infarction drug
March 19, 2025
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.
Post navigation
You could soon GROW your own Ozempic-like weight loss medication at home, scientists claim… – The Sun
Community Conversations: FBI warns of fraud linked to Ozempic, Wegovy – KFOX El Paso